HSA — authorised 28 February 1977
- Marketing authorisation holder: TARO PHARMS NORTH
- Status: likely_approved
HSA authorised Topicort on 28 February 1977
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 28 February 1977.
TARO PHARMS NORTH holds the Singaporean marketing authorisation.